醫療季營收分析

最後更新 2026-01-22 08:39:22 (UTC+8)

醫療季營收趨勢分析

判斷醫療類股公司整體季節調整後季營收成長趨勢，包括季營收季增率、年增率等指標，協助評估產業整體表現與相關概念股投資價值。

醫療類股調整後季營收與 XLV ETF走勢圖

FindBillion.com

季節調整後季營收成長率


季營收季增率	3.5%
季營收年增率	9.6%

醫療季營收與股價相關性分析

判斷醫療類股ETF(XLV) 股價和類股整體季節調整後季營收有無相關性，若中高度相關性，可由整體季節調整後季營收推估股價是否合理，協助評估醫療相關概念股投資價值。

醫療類股整體季節調整後季營收-股價散佈圖

醫療類股整體季節調整後季營收與股價高度相關，相關性越高，參考意義越大。

醫療類股整體季節調整後季營收與股價間的
決定係數

高度相關 0.87

FindBillion.com

醫療相關個股

醫療相關個股列表，包括各概念股的季營收季增率、年增率等指標，協助評估概念股投資價值。

代碼	公司名稱	季營收季增率	季營收年增率
MRNA	Moderna, Inc.	300.2%	-45.2%
BNTX	BioNTech SE	261.5%	22%
RNA	Avidity Biosciences, Inc.	216%	434%
ROIV	Roivant Sciences Ltd.	87.8%	-64.9%
ARGX	argenx SE	79.8%	5.1%
ALNY	Alnylam Pharmaceuticals, Inc.	77.4%	149.3%
HLN	Haleon plc	43.4%	-3.8%
KRYS	Krystal Biotech, Inc.	42.7%	16.6%
CAI	Caris Life Sciences, Inc.	31.5%	168.8%
ABVX	Abivax S.A.	30.8%	-10.3%
INSM	Insmed Incorporated	30.7%	52.4%
MDGL	Madrigal Pharmaceuticals, Inc.	25.8%	362%
BBIO	BridgeBio Pharma, Inc.	25.3%	4318%
GH	Guardant Health, Inc.	17.3%	38.5%
INCY	Incyte Corporation	17%	20%
LLY	Eli Lilly and Company	14.1%	53.9%
AXSM	Axsome Therapeutics, Inc.	14%	63.2%
DOCS	Doximity, Inc.	11.9%	23.2%
NBIX	Neurocrine Biosciences, Inc.	11.5%	27.8%
PFE	Pfizer Inc.	9.3%	-5.9%
NTRA	Natera, Inc.	8.8%	34.7%
MEDP	Medpace Holdings, Inc.	8.7%	23.7%
WST	West Pharmaceutical Services, Inc.	8.6%	7.7%
RGEN	Repligen Corporation	8.5%	21.9%
CI	Cigna Corporation	8.3%	9.5%
JAZZ	Jazz Pharmaceuticals plc	8.1%	6.7%
CAH	Cardinal Health, Inc.	7.7%	22.4%
TAK	Takeda Pharmaceutical Company Limited	7.2%	-5.4%
DHR	Danaher Corporation	6.9%	4.4%
TEVA	Teva Pharmaceutical Industries Limited	6.7%	3.4%
EXEL	Exelixis, Inc.	6.5%	10.8%
UHS	Universal Health Services, Inc.	6.3%	13.4%
SNY	Sanofi	5.8%	-7%
VRTX	Vertex Pharmaceuticals Incorporated	5.7%	11%
AMGN	Amgen Inc.	5.2%	12.4%
REGN	Regeneron Pharmaceuticals, Inc.	4.9%	0.9%
ENSG	The Ensign Group, Inc.	4.5%	19.8%
CVS	CVS Health Corporation	4.4%	7.8%
PODD	Insulet Corporation	4.3%	29.9%
WAT	Waters Corporation	4.3%	8%
RMD	ResMed Inc.	4%	9.1%
RVTY	Revvity, Inc.	3.8%	2.2%
HUM	Humana Inc.	3.5%	11.1%
MRK	Merck & Co., Inc.	3.5%	3.7%
IQV	IQVIA Holdings Inc.	3.4%	5.2%
EW	Edwards Lifesciences Corporation	3.4%	14.7%
IDXX	IDEXX Laboratories, Inc.	3.3%	13.3%
BMY	Bristol-Myers Squibb Company	3.2%	2.8%
GEHC	GE HealthCare Technologies Inc.	3.1%	5.8%
VTRS	Viatris Inc.	3.1%	0.2%
BAX	Baxter International Inc.	3.1%	5%
TMO	Thermo Fisher Scientific Inc.	2.9%	4.9%
EHC	Encompass Health Corporation	2.9%	9.4%
GILD	Gilead Sciences, Inc.	2.8%	3%
UNH	UnitedHealth Group Incorporated	2.7%	12.2%
VEEV	Veeva Systems Inc.	2.6%	16%
PEN	Penumbra, Inc.	2.5%	17.8%
ISRG	Intuitive Surgical, Inc.	2.4%	22.9%
EXAS	Exact Sciences Corporation	2.3%	20%
GMED	Globus Medical, Inc.	2.3%	22.9%
MTD	Mettler-Toledo International Inc.	2.3%	7.9%
COR	Cencora, Inc.	2.1%	5.9%
BRKR	Bruker Corporation	2.1%	-0.5%
HALO	Halozyme Therapeutics, Inc.	2.1%	22.1%
FMS	Fresenius Medical Care AG & Co. KGaA	2%	2.6%
CNC	Centene Corporation	2%	18.2%
MDT	Medtronic plc	1.7%	6.6%
MCK	McKesson Corporation	1.7%	10.1%
ELV	Elevance Health Inc.	1.5%	12.3%
RPRX	Royalty Pharma plc	1.5%	7.9%
HCA	HCA Healthcare, Inc.	1.5%	9.6%
ABBV	AbbVie Inc.	1.2%	9.1%
DXCM	DexCom, Inc.	1.2%	21.6%
ASND	Ascendis Pharma A/S	1.2%	269.4%
A	Agilent Technologies, Inc.	1.1%	9.4%
ABT	Abbott Laboratories	1.1%	6.9%
ATR	AptarGroup, Inc.	1%	5.7%
MOH	Molina Healthcare, Inc.	1%	11%
BDX	Becton, Dickinson and Company	1%	8.3%
ILMN	Illumina, Inc.	0.8%	0.3%
ONC	BeOne Medicines Ltd.	0.7%	41%
QGEN	Qiagen N.V.	0.6%	6.1%
BSX	Boston Scientific Corporation	0.3%	20.3%
COO	The Cooper Companies, Inc.	0.3%	4.6%
SYK	Stryker Corporation	0.2%	10.2%
AZN	AstraZeneca PLC	-0.1%	12%
MASI	Masimo Corporation	-0.2%	-26.4%
STE	STERIS plc	-0.3%	9.9%
UTHR	United Therapeutics Corporation	-0.3%	6.8%
DVA	DaVita Inc.	-0.4%	4.8%
SNN	Smith & Nephew plc	-0.5%	9.3%
CRL	Charles River Laboratories International, Inc.	-0.6%	-0.5%
BTSG	BrightSpring Health Services, Inc. Common Stock	-0.7%	14.7%
JNJ	Johnson & Johnson	-0.8%	9.1%
BIO	Bio-Rad Laboratories, Inc.	-0.9%	0.5%
GRFS	Grifols, S.A.	-1.1%	4%
ALC	Alcon Inc.	-1.3%	6.5%
HQY	HealthEquity, Inc.	-1.7%	7.2%
THC	Tenet Healthcare Corporation	-1.8%	3.3%
SOLV	Solventum Corporation	-2.1%	0.7%
AVTR	Avantor, Inc.	-2.5%	-5.3%
NVO	Novo Nordisk A/S	-2.6%	5.1%
HOLX	Hologic, Inc.	-2.6%	6.2%
NVS	Novartis AG	-2.7%	9%
DGX	Quest Diagnostics Incorporated	-3%	13.2%
ZBH	Zimmer Biomet Holdings, Inc.	-3.1%	9.7%
LH	Labcorp Holdings Inc.	-3.5%	8.6%
ZTS	Zoetis Inc.	-3.8%	0.5%
TECH	Bio-Techne Corporation	-3.9%	-1%
GSK	GSK plc	-4.1%	6.7%
HSIC	Henry Schein, Inc.	-4.1%	5.2%
PHG	Koninklijke Philips N.V.	-4.2%	-1.7%
ALGN	Align Technology, Inc.	-4.8%	1.8%
BMRN	BioMarin Pharmaceutical Inc.	-4.8%	4.1%
ICLR	ICON Public Limited Company	-4.9%	0.6%
ELAN	Elanco Animal Health Incorporated	-6.3%	10.4%
BIIB	Biogen Inc.	-7%	-0.4%
TEM	Tempus AI, Inc.	-10.1%	84.7%
RDY	Dr. Reddy's Laboratories Limited	-51.8%	5.3%
IONS	Ionis Pharmaceuticals, Inc.	-65.7%	17.1%
GMAB	Genmab A/S	-81.7%	-81.6%
ARWR	Arrowhead Pharmaceuticals, Inc.	-91.5%	轉虧為盈%
CYTK	Cytokinetics, Incorporated	-97.9%	318.1%
RVMD	Revolution Medicines, Inc.	-	-
NUVL	Nuvalent, Inc.	-	-
RGC	Regencell Bioscience Holdings Limited	-	-
SMMT	Summit Therapeutics Inc.	-	-
MDLN	Medline Inc.	-	-

警語

1. 資料僅供參考，不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整，需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

醫療類股

醫療季營收趨勢分析

判斷 醫療 類股公司整體季節調整後季營收成長趨勢，包括季營收季增率、年增率等指標，協助評估產業整體表現與相關概念股投資價值。

醫療季營收與股價相關性分析

判斷 醫療 類股ETF(XLV) 股價和類股整體季節調整後季營收有無相關性，若中高度相關性，可由整體季節調整後季營收推估股價是否合理，協助評估醫療相關概念股投資價值。

醫療相關個股

醫療 相關個股列表，包括各概念股的季營收季增率、年增率等指標，協助評估概念股投資價值。

判斷醫療類股公司整體季節調整後季營收成長趨勢，包括季營收季增率、年增率等指標，協助評估產業整體表現與相關概念股投資價值。

判斷醫療類股ETF(XLV) 股價和類股整體季節調整後季營收有無相關性，若中高度相關性，可由整體季節調整後季營收推估股價是否合理，協助評估醫療相關概念股投資價值。

醫療相關個股列表，包括各概念股的季營收季增率、年增率等指標，協助評估概念股投資價值。